CAR T-cell therapy is a new treatment for certain types of blood cancer that involves genetically engineering T cells to target cancer cells. The therapy involves growing and expanding...
Scientists from Chulalongkorn University are studying a new treatment for breast cancer called CAR T-cell therapy. They have created CAR T-cells that target a specific antigen called mucin-1 (MUC1)...
A team of researchers from Chulalongkorn University has developed a highly efficient hybridoma generation and screening strategy to generate high-potency chimeric anti-PD-1 molecules, a protein that plays a significant...